Hepatitis affecting hemodialysis and transplant patients. Its considerations and consequences.
D000906:Antibodies / Q000008:administration & dosage; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000627:therapeutic use; D002102:Cadaver; D002353:Carrier State / Q000175:diagnosis; D006084:Graft Rejection; D006437:Hemodialysis, Home; D006506:Hepatitis A / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control; D006511:Hepatitis B Antigens / Q000032:analysis; D006801:Humans; D007122:Immunoelectrophoresis; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation; D008111:Liver Function Tests; D010564:Personnel, Hospital; D011183:Postoperative Complications; D011241:Prednisone / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*; D014184:Transplantation, Homologous
D000906:Antibodies; D000961:Antilymphocyte Serum; D006511:Hepatitis B Antigens; D007166:Immunosuppressive Agents; D001219:Aspartate Aminotransferases; D001379:Azathioprine; D011241:Prednisone